Cancer, a genetic disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body, is caused by changes to genes that control the…
This poster highlights the impact of an HSSP model on accessing Patient Assistance Program (PAP) funding for oral oncolytic drugs. Government-insured patients received PAP support more often with brand medications…
This poster highlights how HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating the potential for avoidable medical events. Implementing an integrated care model with…
This poster highlights the positive impact of introducing ACP services into a hematology/oncology clinic, leading to successful outcomes and substantial cost savings following HSSP integration. Challenges in cost estimation stemmed…
This research poster examines how HSSP oncology patients had lower hospital utilization rates compared to a national network, indicating potential benefits of an integrated care model with close clinical monitoring…
As a Clinical pharmacist for Shields Health Solutions, I have had the privilege to focus on providing the best care for patients on specialty medications. With our care model, I…
This poster highlights the analysis on CDK4/6 inhibitor patients at HSSPs showed strong and consistent adherence across drug, age group, insurance type, and location, highlighting the impact of the HSSP…
This poster examines how remote placement of an ambulatory clinical pharmacist alongside a pharmacy liaison improved approval rates for specialty oncology medication PAs and appeals, suggesting potential benefits for other…
Shields explores the impact of the cost of oral oncology medications on clinical and economic outcomes in patients with cancer managed by HSSP clinical programs.